---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-022013"
form_type: "8-K/A"
ticker: "ELTP"
cik: "0001053369"
company_name: "ELITE PHARMACEUTICALS INC /NV/"
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T20:52:20.134772+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Elite Pharmaceuticals Corrects Conference Call Date for Q2 Fiscal 2026 Results

## Summary
- Q2 FY2026 financial results (ended Sept 30, 2025) to be released on Friday, November 14, 2025.
- Conference call scheduled for Monday, November 17, 2025 at 11:30 AM EST to discuss results and provide update.
- Form 8-K/A amends prior filing solely to correct the conference call date in Item 7.01.
- Dial-in: 1-800-346-7359 (domestic) or 1-973-528-0008 (international); conference ID 98840.
- Stockholder questions due by 5:00 PM EST on Nov 13 (general) and 7:00 PM EST on Nov 14 (financial).

## SEC filing metadata
- accession: 0001493152-25-022013
- form_type: 8-K/A
- ticker: ELTP
- cik: 0001053369
- company_name: ELITE PHARMACEUTICALS INC /NV/
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053369/000149315225022013/0001493152-25-022013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053369/000149315225022013/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-022013
- JSON: https://secwatch.observer/filing/0001493152-25-022013.json
- Plain text: https://secwatch.observer/filing/0001493152-25-022013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.